4//SEC Filing
Riley Brigit 4
Accession 0001209191-23-015796
CIK 0001501756other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:24 PM ET
Size
5.9 KB
Accession
0001209191-23-015796
Insider Transaction Report
Form 4
Riley Brigit
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+250,000→ 250,000 totalExercise: $0.75Exp: 2033-02-28→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares subject to the option shall vest and become exercisable on the first anniversary of March 1, 2023 (the "Vesting Commencement Date"), and one-forty-eighth (1/48th) of the total number of shares subject to the option shall vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable on the fourth (4th) anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001882857
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:24 PM ET
- Size
- 5.9 KB